日本久久久久久,操久久,精品一二区

產(chǎn)品搜索

產(chǎn)品分類

聯(lián)系我們

聯(lián)系人：蔣經(jīng)理
電話：4008750250
號碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com

產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73049EGFR L858R-T790M-C797S/BaF3

名稱	EGFR L858R-T790M-C797S/BaF3
型號	CBP73049
報價
特點(diǎn)	EGFR L858R-T790M-C797S/BaF3,母細(xì)胞：BaF3，凍存條件：90% FBS+10% DMSO

詳細(xì)內(nèi)容

CBP73049
I. Introduction
Cell Line Name：	EGFR L858R-T790M-C797S/BaF3
Host Cell:	Ba/F3
Stability:	16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)
Application:	Anti-proliferation assay and PD assay
Freeze Medium:	90% FBS+10% DMSO
Complete Culture Medium:	RPMI-1640+10%FBS
Mycoplasma Status:	Negative

II.Background
EGFR is widely recognized for its importance in cancer. Amplification and mutations have been shown to be driving events in many cancer types. Its role in non-small cell lung cancer, glioblastoma and basal-like breast cancers has spurred many research and drug development efforts. Tyrosine kinase inhibitors have shown efficacy in EGFR amplfied tumors, most notably gefitinib and erlotinib. Mutations in EGFR have been shown to confer resistance to these drugs, particularly the variant T790M, which has been functionally characterized as a resistance marker for both of these drugs. The later generation TKI's have seen some success in treating these resistant cases, and targeted sequencing of the EGFR locus has become a common practice in treatment of non-small cell lung cancer. Overproduction of ligands is another possible mechanism of activation of EGFR. ERBB ligands include EGF, TGF-a, AREG, EPG, BTC, HB-EGF, EPR and NRG1-4 (for detailed information please refer to the respective ligand section). In ligand-activated cancers, Cetuximab appears to be more effective than tyrosine-kinase inhibitors.

III. Representative Data
1. WB of EGFR-L858R/T790M/C797S expression

Figure 1. WB of EGFR Expression Lane 1: Negative control Lane 2: EGFR-WT Lane 3: EGFR-L858R/T790M Lane 4: EGFR-L858R/T790M/C797S
2. Sanger sequencing

Figure 2. Sanger Sequencing of EGFR-L858R/T790M/C797S
3. Anti-proliferation assay

Figure 3. Anti-proliferation assay of three reference compounds on the EGFR L858R-T790M-C797S/BaF3 Stable Cell Line